Abstract

Introduction

Testosterone Deficiency (TD) is common in men living with HIV (MLWHIV) and is associated with worse clinical outcomes. This study aimed to evaluate the frequency of TD in MLWHIV and factors potentially associated with this condition.

Methodology

This observational cross-sectional study included MLWHIV aged > 18 years receiving Antiretroviral Therapy (ART). Clinical and laboratory data were collected, and body composition, Bone Mass (BM), Lean Mass (LM), and Fat Mass (FM), were assessed using Dual-energy X-ray Absorptiometry (DXA). TD was defined as Total Testosterone (TT) <300 ng/dL and/or calculated Free Testosterone (cFT) <6.4 ng/dL (Vermeulen’s formula). Data are presented as median (interquartile range, IQR) and n (%).

Results

Eighty-four participants were included from May 2014 to August 2015. Median TT was 396.5 ng/dL (IQR 314.8–490.2), Sex Hormone-Binding Globulin (SHBG) 45.4 nmol/L (IQR 35.1–60.2), and cFT 6.6 ng/dL (IQR 5.3–7.4). TD prevalence was 22.6% by TT and 44% by cFT (p<0.001). Using the cFT criterion, participants with TD were older (50 vs 45 years, p<0.01), had higher prevalence of metabolic syndrome (27% vs 4.3%, p<0.01), increased waist circumference (21.6% vs 4.3%, p<0.05), and lower frequency of normal BM (37.5% vs 67.5%, p<0.05). No differences were observed in CD4 count, ART duration or type, LM, FM, or lipodystrophy.

Conclusion

In MLWHIV, the cFT criterion identified more cases of TD than TT alone. TD in this population is associated with altered bone mass, increased waist circumference, and a higher prevalence of metabolic syndrome, highlighting the importance of systematic evaluation using cFT.

Keywords: Human immunodeficiency virus, Testosterone deficiency, Calculated free testosterone, Body composition, Bone mass, Lean mass, Fat mass.
Fulltext HTML PDF
1800
1801
1802
1803
1804